The Swedish two-county trial twenty years later: Updated mortality results and new insights from long-term follow-up

László Tabár, Bedrich Vitak, Hsiu Hsi Chen, Stephen W. Duffy, Ming Fang Yen, Ching Feng Chiang, Ulla Brith Krusemo, Tibor Tot, Robert A. Smith

研究成果: 雜誌貢獻 › 文章

389 引文 (Scopus)

摘要

The benefit of invitation to mammographic screening observed in this trial is maintained as a highly significant 32% reduction in breast cancer mortality. Mammographic screening for breast cancer continues to save lives after up to 20 years. Screening derives this benefit by improving the distribution of tumors diagnosed with respect to prognostic categories based on node status, size, and histology of tumors. There is potential for modern screening programs with shorter interscreening intervals to achieve even greater improvements in prognostic category and greater reductions in breast cancer mortality. Mammography can discriminate a subpopulation of high-risk cases, those displaying casting-type calcifications on the mammogram, among very small tumors, with fundamental implications for diagnosis and treatment.
原文英語
頁（從 - 到）625-651
頁數27
期刊Radiologic Clinics of North America
卷38
發行號4
出版狀態已發佈 - 2000
對外發佈Yes

指紋

Breast Neoplasms
Mortality
Neoplasms
Mammography
Histology
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

引用此文

Tabár, L., Vitak, B., Chen, H. H., Duffy, S. W., Yen, M. F., Chiang, C. F., ... Smith, R. A. (2000). The Swedish two-county trial twenty years later: Updated mortality results and new insights from long-term follow-up. Radiologic Clinics of North America, 38(4), 625-651.

The Swedish two-county trial twenty years later : Updated mortality results and new insights from long-term follow-up. / Tabár, László; Vitak, Bedrich; Chen, Hsiu Hsi; Duffy, Stephen W.; Yen, Ming Fang; Chiang, Ching Feng; Krusemo, Ulla Brith; Tot, Tibor; Smith, Robert A.

於: Radiologic Clinics of North America, 卷 38, 編號 4, 2000, p. 625-651.

研究成果: 雜誌貢獻 › 文章

Tabár, L, Vitak, B, Chen, HH, Duffy, SW, Yen, MF, Chiang, CF, Krusemo, UB, Tot, T & Smith, RA 2000, 'The Swedish two-county trial twenty years later: Updated mortality results and new insights from long-term follow-up', Radiologic Clinics of North America, 卷 38, 編號 4, 頁 625-651.
Tabár L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF 等. The Swedish two-county trial twenty years later: Updated mortality results and new insights from long-term follow-up. Radiologic Clinics of North America. 2000;38(4):625-651.
Tabár, László ; Vitak, Bedrich ; Chen, Hsiu Hsi ; Duffy, Stephen W. ; Yen, Ming Fang ; Chiang, Ching Feng ; Krusemo, Ulla Brith ; Tot, Tibor ; Smith, Robert A. / The Swedish two-county trial twenty years later : Updated mortality results and new insights from long-term follow-up. 於: Radiologic Clinics of North America. 2000 ; 卷 38, 編號 4. 頁 625-651.
@article{a7082fb531134908b00b8268ec09e2e2,
title = "The Swedish two-county trial twenty years later: Updated mortality results and new insights from long-term follow-up",
abstract = "The benefit of invitation to mammographic screening observed in this trial is maintained as a highly significant 32{\%} reduction in breast cancer mortality. Mammographic screening for breast cancer continues to save lives after up to 20 years. Screening derives this benefit by improving the distribution of tumors diagnosed with respect to prognostic categories based on node status, size, and histology of tumors. There is potential for modern screening programs with shorter interscreening intervals to achieve even greater improvements in prognostic category and greater reductions in breast cancer mortality. Mammography can discriminate a subpopulation of high-risk cases, those displaying casting-type calcifications on the mammogram, among very small tumors, with fundamental implications for diagnosis and treatment.",
author = "L{\'a}szl{\'o} Tab{\'a}r and Bedrich Vitak and Chen, {Hsiu Hsi} and Duffy, {Stephen W.} and Yen, {Ming Fang} and Chiang, {Ching Feng} and Krusemo, {Ulla Brith} and Tibor Tot and Smith, {Robert A.}",
year = "2000",
language = "English",
volume = "38",
pages = "625--651",
journal = "Radiologic Clinics of North America",
issn = "0033-8389",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - The Swedish two-county trial twenty years later

T2 - Updated mortality results and new insights from long-term follow-up

AU - Tabár, László

AU - Vitak, Bedrich

AU - Chen, Hsiu Hsi

AU - Duffy, Stephen W.

AU - Yen, Ming Fang

AU - Chiang, Ching Feng

AU - Krusemo, Ulla Brith

AU - Tot, Tibor

AU - Smith, Robert A.

PY - 2000

Y1 - 2000

N2 - The benefit of invitation to mammographic screening observed in this trial is maintained as a highly significant 32% reduction in breast cancer mortality. Mammographic screening for breast cancer continues to save lives after up to 20 years. Screening derives this benefit by improving the distribution of tumors diagnosed with respect to prognostic categories based on node status, size, and histology of tumors. There is potential for modern screening programs with shorter interscreening intervals to achieve even greater improvements in prognostic category and greater reductions in breast cancer mortality. Mammography can discriminate a subpopulation of high-risk cases, those displaying casting-type calcifications on the mammogram, among very small tumors, with fundamental implications for diagnosis and treatment.

AB - The benefit of invitation to mammographic screening observed in this trial is maintained as a highly significant 32% reduction in breast cancer mortality. Mammographic screening for breast cancer continues to save lives after up to 20 years. Screening derives this benefit by improving the distribution of tumors diagnosed with respect to prognostic categories based on node status, size, and histology of tumors. There is potential for modern screening programs with shorter interscreening intervals to achieve even greater improvements in prognostic category and greater reductions in breast cancer mortality. Mammography can discriminate a subpopulation of high-risk cases, those displaying casting-type calcifications on the mammogram, among very small tumors, with fundamental implications for diagnosis and treatment.

UR - http://www.scopus.com/inward/record.url?scp=0033889950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033889950&partnerID=8YFLogxK

M3 - Article

C2 - 10943268

AN - SCOPUS:0033889950

VL - 38

SP - 625

EP - 651

JO - Radiologic Clinics of North America

JF - Radiologic Clinics of North America

SN - 0033-8389

IS - 4

ER -

存取文件